Our Science – MIP Website
Molecular Imaging Program
| Small Animal Imaging Program-Frederick - The MIP maintains a close relationship with the Small Animal Imaging Program, NCI located in Frederick, Maryland. This is a full service animal imaging facility. Dr. Choyke is on the steering committee and his group conducts research with the cooperation of Dr. Joseph Kalen and his staff.|
| National Cancer Institute - The Center for Cancer Research (CCR) is home to more than 250 scientists and clinicians working in intramural research at NCI. CCR is organized into over 50 branches and laboratories, each one grouping scientists with complementary interests.|
| NCI Frederick - NCI-Frederick partners with university, government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS.|
| National Institutes of Health
- The NIH mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability.
| Cancer Imaging Program - Promotes and supports cancer-related basic, translational, and clinical research in imaging sciences and technology, and integration and application of these imaging discoveries and developments to the understanding of cancer biology and to the clinical management of cancer and cancer risk.|
| Technology Transfer Center - Technology Transfer Center (TTC) provides a complete array of services to support the National Cancer Institute's technology development activities. To ensure that these activities comport with Federal statutes, regulations and the policies of the National Institutes of Health, a large part of TTC's responsibilities includes the day-to-day negotiations of transactional agreements between the NCI and outside parties, including universities, pharmaceutical and biotechnology companies.|
| Urologic Oncology Branch - The Urologic Oncology Branch conducts clinical and basic research designed to develop better methods for detection, prevention, and therapy of patients with genitourinary malignancies. The primary focus of the Urologic Oncology Branch is the study of the genes associated with initiation and progression of kidney and prostate cancers.|
This page was last updated on 9/8/2011.